annual EBIT:
-$139.59M-$87.75M(-169.28%)Summary
- As of today (May 29, 2025), VRNA annual earnings before interest & taxes is -$139.59 million, with the most recent change of -$87.75 million (-169.28%) on December 31, 2024.
- During the last 3 years, VRNA annual EBIT has fallen by -$84.34 million (-152.66%).
- VRNA annual EBIT is now -1163125.00% below its all-time high of -$12.00 thousand, reached on December 31, 2005.
Performance
VRNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$6.36M+$8.88M(+58.25%)Summary
- As of today (May 29, 2025), VRNA quarterly earnings before interest & taxes is -$6.36 million, with the most recent change of +$8.88 million (+58.25%) on March 31, 2025.
- Over the past year, VRNA quarterly EBIT has increased by +$17.09 million (+72.87%).
- VRNA quarterly EBIT is now -156.49% below its all-time high of $11.26 million, reached on September 30, 2021.
Performance
VRNA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$122.50M+$17.09M(+12.24%)Summary
- As of today (May 29, 2025), VRNA TTM earnings before interest & taxes is -$122.50 million, with the most recent change of +$17.09 million (+12.24%) on March 31, 2025.
- Over the past year, VRNA TTM EBIT has dropped by -$63.48 million (-107.57%).
- VRNA TTM EBIT is now -9820.31% below its all-time high of -$1.23 million, reached on June 30, 2016.
Performance
VRNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VRNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -169.3% | +72.9% | -107.6% |
| 3 y3 years | -152.7% | +74.2% | -108.3% |
| 5 y5 years | -244.8% | +48.3% | -178.9% |
VRNA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -169.3% | at low | at high | +90.7% | -152.7% | +12.2% |
| 5 y | 5-year | -244.8% | at low | -156.5% | +90.7% | -214.4% | +12.2% |
| alltime | all time | <-9999.0% | at low | -156.5% | +90.7% | -9820.3% | +12.2% |
VRNA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$6.36M(-58.2%) | -$122.50M(-12.2%) |
| Dec 2024 | -$139.59M(+169.3%) | -$15.24M(-53.6%) | -$139.59M(+1.2%) |
| Sep 2024 | - | -$32.83M(-51.8%) | -$137.91M(+15.6%) |
| Jun 2024 | - | -$68.06M(+190.2%) | -$119.32M(+102.2%) |
| Mar 2024 | - | -$23.45M(+72.9%) | -$59.02M(+13.8%) |
| Dec 2023 | -$51.84M(-23.7%) | -$13.56M(-4.8%) | -$51.84M(+7.0%) |
| Sep 2023 | - | -$14.24M(+83.6%) | -$48.47M(-2.5%) |
| Jun 2023 | - | -$7.76M(-52.3%) | -$49.69M(-16.5%) |
| Mar 2023 | - | -$16.28M(+59.7%) | -$59.53M(-12.4%) |
| Dec 2022 | -$67.93M(+23.0%) | -$10.19M(-34.1%) | -$67.93M(-16.3%) |
| Sep 2022 | - | -$15.47M(-12.1%) | -$81.16M(+49.1%) |
| Jun 2022 | - | -$17.60M(-28.7%) | -$54.43M(-7.4%) |
| Mar 2022 | - | -$24.67M(+5.3%) | -$58.79M(+6.4%) |
| Dec 2021 | -$55.25M(-15.0%) | -$23.43M(-308.0%) | -$55.25M(-2.3%) |
| Sep 2021 | - | $11.26M(-151.3%) | -$56.57M(-34.8%) |
| Jun 2021 | - | -$21.96M(+3.9%) | -$86.72M(+17.5%) |
| Mar 2021 | - | -$21.13M(-14.7%) | -$73.79M(+13.6%) |
| Dec 2020 | -$64.97M(+60.5%) | -$24.75M(+31.1%) | -$64.96M(+54.0%) |
| Sep 2020 | - | -$18.89M(+109.3%) | -$42.19M(+8.3%) |
| Jun 2020 | - | -$9.02M(-26.6%) | -$38.96M(-11.3%) |
| Mar 2020 | - | -$12.29M(+518.5%) | -$43.92M(+8.9%) |
| Dec 2019 | -$40.49M | -$1.99M(-87.3%) | -$40.34M(-6.2%) |
| Sep 2019 | - | -$15.65M(+11.9%) | -$42.99M(+35.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$13.98M(+60.5%) | -$31.81M(+73.5%) |
| Mar 2019 | - | -$8.72M(+87.9%) | -$18.33M(-42.9%) |
| Dec 2018 | -$30.49M(-10.2%) | -$4.64M(+3.7%) | -$32.08M(-16.9%) |
| Sep 2018 | - | -$4.47M(+779.2%) | -$38.60M(-19.6%) |
| Jun 2018 | - | -$508.60K(-97.7%) | -$48.00M(-9.2%) |
| Mar 2018 | - | -$22.46M(+101.3%) | -$52.87M(+57.5%) |
| Dec 2017 | -$33.96M(+367.6%) | -$11.16M(-19.5%) | -$33.57M(+36.8%) |
| Sep 2017 | - | -$13.86M(+157.3%) | -$24.55M(+84.3%) |
| Jun 2017 | - | -$5.39M(+70.4%) | -$13.32M(+45.3%) |
| Mar 2017 | - | -$3.16M(+47.9%) | -$9.17M(+52.6%) |
| Dec 2016 | -$7.26M(-45.2%) | -$2.14M(-18.8%) | -$6.01M(+55.3%) |
| Sep 2016 | - | -$2.63M(+113.2%) | -$3.87M(+213.2%) |
| Jun 2016 | - | -$1.23M | -$1.23M |
| Dec 2015 | -$13.25M(+124.4%) | - | - |
| Dec 2014 | -$5.90M(+27.1%) | - | - |
| Dec 2013 | -$4.64M(+11.2%) | - | - |
| Dec 2012 | -$4.18M(+45.6%) | - | - |
| Dec 2011 | -$2.87M(-1.2%) | - | - |
| Dec 2010 | -$2.90M(+12.3%) | - | - |
| Dec 2009 | -$2.59M(+19.0%) | - | - |
| Dec 2008 | -$2.17M(-16.0%) | - | - |
| Dec 2007 | -$2.59M(+97.0%) | - | - |
| Dec 2006 | -$1.31M(>+9900.0%) | - | - |
| Dec 2005 | -$12.00K | - | - |
FAQ
- What is Verona Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Verona Pharma?
- What is Verona Pharma annual EBIT year-on-year change?
- What is Verona Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Verona Pharma?
- What is Verona Pharma quarterly EBIT year-on-year change?
- What is Verona Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Verona Pharma?
- What is Verona Pharma TTM EBIT year-on-year change?
What is Verona Pharma annual earnings before interest & taxes?
The current annual EBIT of VRNA is -$139.59M
What is the all time high annual EBIT for Verona Pharma?
Verona Pharma all-time high annual earnings before interest & taxes is -$12.00K
What is Verona Pharma annual EBIT year-on-year change?
Over the past year, VRNA annual earnings before interest & taxes has changed by -$87.75M (-169.28%)
What is Verona Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of VRNA is -$6.36M
What is the all time high quarterly EBIT for Verona Pharma?
Verona Pharma all-time high quarterly earnings before interest & taxes is $11.26M
What is Verona Pharma quarterly EBIT year-on-year change?
Over the past year, VRNA quarterly earnings before interest & taxes has changed by +$17.09M (+72.87%)
What is Verona Pharma TTM earnings before interest & taxes?
The current TTM EBIT of VRNA is -$122.50M
What is the all time high TTM EBIT for Verona Pharma?
Verona Pharma all-time high TTM earnings before interest & taxes is -$1.23M
What is Verona Pharma TTM EBIT year-on-year change?
Over the past year, VRNA TTM earnings before interest & taxes has changed by -$63.48M (-107.57%)